- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Total investment in Molecular Imprints $4.5 million
Harris & Harris Group, Inc.®, announced today that it invested an
additional $2,500,000 in privately held Molecular Imprints, Inc., of
Austin, TX, bringing its total investment in Molecular Imprints to
$4,500,000. The investment was as part of a Series C financing that
raised $17 million in the first closing of a planned $25 million
Series C financing. Molecular Imprints provides enabling
lithography systems for manufacturing applications in: nano devices,
LEDs for solid state lighting, magnetic data storage for micro disk
drives and others. Other investors participating in this financing
include Dai Nippon Printing Company (DNP), Alloy Ventures, Motorola
Ventures, Draper Fisher Jurvetson, Hakuto Co., Ltd., Asset
Management and others. Molecular Imprints will use the money to
expand its Imprio® product line.
Harris & Harris Group is a publicly traded venture capital company that now makes initial investments exclusively in tiny technology, including nanotechnology, microsystems and microelectromechanical systems (MEMS). The Company's last 24 initial private equity investments have been in tiny-technology enabled companies. The Company has 20,756,345 shares of common stock outstanding.
Detailed information about Harris & Harris Group and its holdings can be found on its website at www.TinyTechVC.com.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Nanotech Grants Options September 22nd, 2016
Arrowhead Pharmaceuticals to Present at Upcoming September Conferences September 1st, 2016
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
Metamaterial device allows chameleon-like behavior in the infrared October 28th, 2016
The molecular mechanism that blocks membrane receptors has been identified: The work in which the Ikerbasque researcher of the Biofisika Institute Xabier Contreras has participated has been published in the journal Cell October 27th, 2016
Imaging where cancer drugs go in the body could improve treatment October 26th, 2016